Form 8-K - Current report:
SEC Accession No. 0001493152-24-048090
Filing Date
2024-11-29
Accepted
2024-11-29 06:05:44
Documents
55
Period of Report
2024-09-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 32708
2 ex99-1.htm   iXBRL EX-99.1 1032321
  Complete submission text file 0001493152-24-048090.txt   4728939

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE rgbp-20240930.xsd EX-101.SCH 36323
4 XBRL CALCULATION FILE rgbp-20240930_cal.xml EX-101.CAL 44061
5 XBRL DEFINITION FILE rgbp-20240930_def.xml EX-101.DEF 183380
6 XBRL LABEL FILE rgbp-20240930_lab.xml EX-101.LAB 276511
7 XBRL PRESENTATION FILE rgbp-20240930_pre.xml EX-101.PRE 236911
58 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 582396
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

EIN.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-191725 | Film No.: 241513050
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)